A

bill to allow Medicare to negotiate drug prices may be put forward in Congress within two or three weeks, legislators said after a closed-door meeting with President Trump.

The outcome of the meeting between Trump and Representative Elijah Cummings (D-Md.) solidifies a stated aim for both politicians: lower drug prices by letting Medicare negotiate with drug makers.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.